NDC 55292-820 – Enjaymo
Sutimlimab 50 mg/mL · Injection, Solution, Concentrate · Intravenous
Product NDC55292-820
Product details
- Brand name
- Enjaymo
- Generic name
- Sutimlimab-jome
- Labeler
- Recordati Rare Diseases, Inc.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- BLA · BLA761164
- Marketed since
- February 4, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Classical Complement Pathway Inhibitor
Active ingredients
- Sutimlimab 50 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55292-820-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55292-820-01) / 22 mL in 1 VIAL, SINGLE-DOSE | Jun 25, 2025 |